Metformin pharmacogenomics: Current status and future directions
- Author(s): Giacomini, Kathleen
- Pawlyk, AC
- Giacomini, KM
- McKeon, C
- Shuldiner, AR
- Florez, JC
- et al.
Published Web Locationhttp://europepmc.org/articles/PMC4113063?pdf=render
The incidence of type 2 diabetes (T2D) and its costs to the health care system continue to rise. Despite the availability of at least 10 drug classes for the treatment of T2D, metformin remains the most widely used firstline pharmacotherapy for its treatme
Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.